Welcome to our dedicated page for Trupanion SEC filings (Ticker: TRUP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Trupanion, Inc. (NASDAQ: TRUP) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its business as a provider of medical insurance for cats and dogs. These SEC filings cover areas such as financial performance, risk factors, capital structure, governance, and material agreements that shape the company’s operations and its TRUP stock profile.
Key filings for Trupanion include annual reports on Form 10-K, which describe its subscription and other business segments, geographic reach, insurance entities, and risk considerations; and quarterly reports on Form 10-Q, which update investors on revenue from subscription and other business, enrolled pet counts, net income or loss, cash flows, and technology and development spending. Current reports on Form 8-K disclose material events, such as new credit agreements, earnings releases, and board appointments.
For example, Trupanion has used Form 8-K to report entering into a credit agreement with PNC Bank that provides term loan and revolving credit facilities secured by substantially all of the company’s and certain subsidiaries’ assets, and to announce the appointment of a new independent director to its board. Other 8-K filings reference the issuance of press releases detailing quarterly financial results.
Investors can also review Trupanion’s disclosures on non-GAAP financial measures, forward-looking statements, and risk factors, which are discussed in its periodic reports and referenced in earnings-related filings. These documents explain how the company views metrics such as adjusted EBITDA, net acquisition cost, and cash flow, and outline factors that could affect future performance, including claims trends, retention, regulatory constraints, and capital requirements.
On this page, Stock Titan presents Trupanion’s SEC filings alongside AI-powered summaries that highlight the main points of lengthy documents, such as 10-K and 10-Q reports. Users can quickly identify important information on segment performance, debt arrangements, and governance changes, while still having access to the full text of each filing for deeper review.
Trupanion, Inc. (TRUP) Form 4 summary: Brenna McGibney, Chief Administration Officer, reported multiple restricted stock unit (RSU) vesting-related transactions on 08/25/2025. Several RSU tranches converted into common stock on a one-for-one basis, with amounts reported as acquired (codes M) and shares withheld by the issuer to satisfy tax withholding (codes F) at a withheld price of $45.83 per share. Following the reported transactions, Ms. McGibney beneficially owns varying direct share totals across tranches (examples include 3,433, 3,417, 3,872, and 3,692 shares). The filing explains grant and vesting schedules for RSUs awarded in 2022 and 2023.
Insider vesting and tax withholding recorded for Trupanion, Inc. (TRUP). Steve Weinrauch, an executive (EVP, North America & Vet Strategy), had restricted stock units (RSUs) vest on 08/22/2025 that converted into common stock. The filing shows two vesting events: 2,932 RSUs from a 2025 grant and 2,028 RSUs from a 2024 grant converted to common shares. The report discloses that the issuer withheld 713 and 493 shares, respectively, to satisfy income tax withholding obligations, so the net beneficial ownership changed accordingly. Following the transactions, Weinrauch beneficially owned 17,590 shares attributable to the 2025 grant and 4,058 shares attributable to the 2024 grant, with total reported common shares held directly at the listed amounts.
Margaret Tooth, CEO and Director of Trupanion, Inc. (TRUP), reported multiple restricted stock unit (RSU) vesting events on 08/22/2025 that converted into common stock. The Form 4 shows the vesting/conversion of RSUs into shares in several tranches (12,170; 313; 6,250; 6,250), with the issuer withholding shares to satisfy tax withholding obligations (4,788; 123; 2,459; 2,459) at a disclosed withholding price of $46.63 per share. The document lists resulting beneficial ownership counts after each reported transaction (examples include 141,466; 136,678; 136,991; 136,868; 143,118; 140,659; 146,909; 144,450). The RSUs convert one-for-one into common stock and have differing vest schedules and future vesting dates noted in the filing.
John R. Gallagher, Chief Operating Officer and director of Trupanion, Inc. (TRUP), reported RSU vesting and related share withholding on 08/22/2025. The filing shows the conversion/vesting of 3,327 and 2,570 restricted stock units into common stock, increasing his direct common stock holdings to 32,053 and 31,428 shares on two reported lines respectively. The company withheld 810 and 625 shares to satisfy income tax withholding obligations at an indicated price of $46.63 per share; those withheld shares are disclosed as dispositions and do not represent open-market sales. The RSUs originate from grants dated February 27, 2025 (26,619 RSUs) and February 27, 2024 (20,559 RSUs) with standard multi-quarter vesting schedules.
Emily Dreyer, Chief Revenue Officer of Trupanion, Inc. (TRUP), reported insider transactions on a Form 4 showing restricted stock units (RSUs) that vested on 08/22/2025. The filing discloses conversion of RSUs into a total of 3,589 shares of common stock acquired (2,249 and 1,340 shares) and the withholding of 873 shares (547 and 326) to satisfy tax obligations at a price of $46.63 per withheld share. After the transactions Dreyer beneficially owned 8,043 shares of common stock in the aggregate, with 4,498 shares shown as directly owned following the reported vesting activity. The RSUs originated from grants on February 27, 2024 (17,991 RSUs) and February 27, 2025 (unspecified total), each vesting on a scheduled quarterly basis after an initial 1/8th vesting date.
Simon Wheeler, Executive Vice President, Trupanion International, reported transactions on 08/22/2025 relating to the vesting of restricted stock units (RSUs) granted in 2024 and 2025. Several RSU vesting events converted units into common stock, resulting in multiple acquisitions of shares (totaling 2,991 shares acquired on that date across three vesting tranches) and contemporaneous withholding by the issuer to satisfy tax obligations (total withheld: 1,404 shares disposed at $46.63 per share). After these transactions, the reporting person beneficially owned between 17,278 and 18,804 shares across the reported lines depending on the line item. The filing notes the RSUs convert one-for-one to common stock and describes original grant schedules and vesting mechanics.
Insider transactions by Brenna McGibney, Chief Administration Officer at Trupanion, Inc. (TRUP). The Form 4 reports a sale of 2,390 shares of common stock on 06/02/2025 at $45.17 per share. On 08/22/2025 the filing discloses multiple restricted stock unit (RSU) vesting events and related withholding: the reporting person was granted RSUs in 2024 and 2025 that converted into common stock, with shares withheld to satisfy tax withholding obligations (these withheld shares are not sales). Post-transactions, non-derivative beneficial ownership totals are shown across several lines, with the last reported direct common stock holdings at 3,402 shares. The Form 4 is signed by an attorney-in-fact on behalf of McGibney.
Trupanion, Inc. (TRUP) Chief Financial Officer Fawwad Qureshi reported transactions on 08/22/2025 related to vested restricted stock units (RSUs). The filing shows RSUs converted into common stock on a one-for-one basis and portions of the vested shares were withheld by the issuer to satisfy income tax withholding obligations. The Form 4 discloses withheld share counts and a per-share withholding price of $46.63 for the withheld shares. The filing also lists the underlying RSU grants that gave rise to the vesting: 7,304 RSUs, 5,000 RSUs, and 41,980 RSUs (grants dated February 27, 2024 and February 27, 2025) with scheduled vesting schedules described in the explanation. The report is signed by an attorney-in-fact on behalf of Mr. Qureshi and dated 08/26/2025.
Form 144 notice for Trupanion, Inc. (TRUP) reports a proposed sale of 2,800 shares of Common stock through Morgan Stanley Smith Barney LLC on 08/26/2025 with an aggregate market value of $127,573.88. The filing lists total shares outstanding as 42,994,675. The securities were acquired as restricted stock from the issuer on 08/25/2025 (1,971 shares) and 08/22/2025 (829 shares), with payment dates matching acquisition dates and marked as Not Applicable for non-cash consideration. The filing also discloses prior sales by the same person: 2,534 shares sold on 05/29/2025 for $122,405.63 and 828 shares sold on 05/27/2025 for $37,698.84. The notice includes the standard signature representation that the seller is not aware of undisclosed material adverse information.
Emily Dreyer, Chief Revenue Officer of Trupanion, Inc. (TRUP), was granted 10,108 restricted stock units (RSUs) on 08/15/2025. Each RSU converts one-for-one into common stock and the reported post-transaction beneficial ownership is 10,108 shares held directly. The RSUs vest as to one-quarter of the total on 08/25/2026 and thereafter 1/16th of the total each quarter, subject to continued service. The grant was reported on Form 4 and signed by an attorney-in-fact on 08/19/2025.